Pricing Log in Create free account

Evotec AG (EVO) vs Tilray Brands, Inc. (TLRY)

Evotec AG and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Evotec AG is the larger, with a market value of $630.4M against $415.3M — 1.5× the size. Tilray Brands, Inc. grew revenue faster over the last twelve months: 15.9% against 2.15%. Tilray Brands, Inc. has the higher net margin (−17.1% vs −26.2%) and the lower return on invested capital (−3.21% vs 0.00%). Across the 18 metrics below, Evotec AG leads on 9 and Tilray Brands, Inc. on 9.

Valuation

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.72 0.39 2.08
P/B 0.81 0.23 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.74 0.52 2.87
Earnings yield (36.25%) (49.82%) (15.94%)
Free cash flow yield (32.04%) (49.10%) 0.00%

Profitability

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Gross margin 11.42% 29.12% 53.51%
Operating margin (21.35%) (9.26%) 0.00%
Net margin (26.20%) (17.05%) (2.45%)
Free cash flow margin 0.00% (19.10%) 0.00%
Return on equity 0.00% (10.50%) (0.80%)
Return on assets 0.00% (7.45%) (1.67%)
Return on invested capital 0.00% (3.21%) 0.00%

Growth

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 2.15% 15.93% 5.22%
EPS growth (last fiscal year) 44.89% 95.57% 42.91%
Revenue growth, 5-year CAGR 9.28% 7.82% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Debt to equity 0.72 0.22 0.04
Current ratio 2.33 1.88 2.41
Net debt to EBITDA (0.64) 11.34 1.01

Dividend

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric EVO TLRY Drug Manufacturers Specialty & Generic median
Market cap 630.44m 415.28m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack